🇺🇸 FDA
Pipeline program

PegIntron (peginterferon alfa-2b)

P03833

Phase 3 mab terminated

Quick answer

PegIntron (peginterferon alfa-2b) for Hepatitis C, Chronic is a Phase 3 program (mab) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Hepatitis C, Chronic
Phase
Phase 3
Modality
mab
Status
terminated

Clinical trials